- Title: Subtitle
- Novel use of abatacept and ruxolitinib as salvage therapy in steroid-refractory immune checkpoint blockade-induced myocarditis with myasthenia and myositis overlap syndrome
- Creators
- Stefano H. Byer - Department of Internal Medicine, University of Iowa Hospitals and Clinics, Iowa City, IA, United StatesColten Stewart - Division of Cardiology, Department of Internal Medicine, University of Iowa Hospitals and Clinics, Iowa City, IA, United StatesShareef Mansour - University of IowaUdhayvir S. Grewal - Division of Hematology, Oncology and Blood and Marrow Transplantation, Department of Internal Medicine, University of Iowa Hospitals, Iowa City, IA, United States
- Resource Type
- Letter/Communication
- Publication Details
- European journal of cancer (1990), Vol.202, 114027
- Publisher
- Elsevier Ltd
- DOI
- 10.1016/j.ejca.2024.114027
- PMID
- 38507971
- ISSN
- 0959-8049
- eISSN
- 1879-0852
- Language
- English
- Date published
- 05/2024
- Academic Unit
- Internal Medicine
- Record Identifier
- 9984573830102771
Letter/Communication
Novel use of abatacept and ruxolitinib as salvage therapy in steroid-refractory immune checkpoint blockade-induced myocarditis with myasthenia and myositis overlap syndrome
European journal of cancer (1990), Vol.202, 114027
05/2024
DOI: 10.1016/j.ejca.2024.114027
PMID: 38507971
Details
Metrics
4 Record Views